17 June 2009 - Seattle, Washington - Becton, Dickinson and Company (BD) and the Foundation for Innovative New Diagnostics (FIND), today announced reduction in the cost of liquid culture testing.
The agreement lowers the cost of BD MGIT™ reagents, which will now be sold at an 80% discount. BD’s TB diagnostic technologies utilize liquid culture, a TB testing protocol that provides results faster than traditional, solid media culture.
The price reduction arises from a November 2007 agreement between BD and FIND. At that time, BD agreed to reduce already below-market prices on completion of 3.5 million tests, a milestone achieved this month.